Prediction of drug-drug plasma protein binding interactions of resveratrol in combination with celecoxib and leflunomide by molecular docking combined with an ultrafiltration technique

Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Research Institute of Integrated Traditional Chinese and Western Medicine Anhui Academy of Chinese Medicine, Key Laboratory of Chinese Herbal Compound Formula in Anhui Province HefeiChina

Hua, Fang

Pharmacy School, Anhui Xinhua UniversityHefei, China

Natural Products Laboratory, International Joint Lab of Tea Chemistry and Health Effects, State Key Laboratory of Tea Plant Biology and Utilization Anhui Agricultural UniversityHefei, China

Langue:: Anglais

Périodicité:: 4 fois par an
Sujets de la revue:: Pharmacie, Pharmacie, autres

RSS Feed de la revue

Prediction of drug-drug plasma protein binding interactions of resveratrol in combination with celecoxib and leflunomide by molecular docking combined with an ultrafiltration technique

Peng Zhou

Fang Hua

Publié en ligne: 01 nov. 2019

Pages: 111 - 119

Accepté: 20 mars 2019

DOI: https://doi.org/10.2478/acph-2019-0056

Mots clésresveratrol, celecoxib, leflunomide, molecular docking, plasma protein binding, ultrafiltration

© 2020 Peng Zhou et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Mots clés
resveratrol, celecoxib, leflunomide, molecular docking, plasma protein binding, ultrafiltration